Abbott Laboratories (ABT) EV to FCF (2009 - 2026)

Abbott Laboratories has disclosed EV to FCF across 18 years of filings, most recently posting 76.38 for Q2 2026.

• In Q2 2026, EV to FCF fell 48.63% year-over-year to 76.38; the TTM figure through Jun 2026 stood at 19.44 (down 42.68% YoY), while the FY2025 annual figure was 28.32, down 4.56% from the prior year.
• EV to FCF came in at 76.38 for Q2 2026 at Abbott Laboratories, down from 187.97 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 305.12 in Q1 2024 to a low of 68.75 in Q3 2022.
• Average EV to FCF over 5 years is 138.57, with a median of 109.84 recorded in 2022.
• Year-over-year, EV to FCF jumped 191.9% in 2023 and plunged 53.23% in 2024.
• Over 5 years, EV to FCF stood at 105.4 in 2022, then slipped by 23.56% to 80.57 in 2023, then increased by 8.89% to 87.73 in 2024, then dropped by 9.1% to 79.75 in 2025, then declined by 4.23% to 76.38 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 76.38 in Q2 2026, 187.97 in Q1 2026, and 79.75 in Q4 2025.